Aarti Drugs informs about updates on buyback offer

17 Jan 2018 Evaluate

Inga Capital (Formerly Inga Capital) (Manager to the Buyback Offer) has submitted a copy of Draft Letter of Offer for the attention of Equity Shareholders / Beneficial Owners of Aarti Drugs (Target Company).

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

319.40 -11.20 (-3.39%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×